Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.89
+0.50 (1.76%)
May 6, 2026, 1:05 PM EDT - Market open
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025.
Employees
558
Change
n/a
Growth
n/a
Revenue / Employee
$2,340,350
Profits / Employee
$675,192
Market Cap
1.88B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Harmony Biosciences Holdings | 293 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
GLPG News
- 5 days ago - Oversold Conditions For Galapagos (GLPG) - Nasdaq
- 7 days ago - Galapagos NV: Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - Finanz Nachrichten
- 7 days ago - Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - GlobeNewsWire
- 5 weeks ago - Galapagos NV Transcript: Collaboration - Transcripts
- 5 weeks ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 5 weeks ago - Galapagos NV: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten
- 5 weeks ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 5 weeks ago - Galapagos NV: Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - Finanz Nachrichten